FDA's Advisory Committees to Hold Joint Meeting on Reproductive Health Drugs and Drug Safety

Summary

The FDA's Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee will hold a joint meeting to discuss reproductive health drugs and drug safety, according to a recent notice from the FDA.